文献速递糖尿病

通过数据驱动聚类分析识别并验证妊娠期糖尿病亚组

Identification and validation of gestational diabetes subgroups by data-driven cluster analysis.
PubMed 文献 · Diabetologia · 2024-05-27

这项队列研究分析了2015至2022年两家欧洲中心共2682例妊娠期糖尿病女性的数据,采用k-means、k-medoids和凝聚层次聚类等方法,基于常规临床变量识别出三个亚组,各亚组在降糖药物需求和大于胎龄儿风险上存在差异。

要点

  • 基于母亲年龄、孕前BMI及OGTT空腹、60分钟和120分钟血糖可识别三个妊娠期糖尿病亚组。
  • 第1组降糖药物需求为39.6%,高于第2组的12.9%和第3组的10.0%(p<0.0001)。
  • 第1组大于胎龄儿风险更高,外部验证队列中第2组与第3组的胰岛素治疗类型存在差异。

核心结论

  • 研究结果证实妊娠期糖尿病具有异质性,识别亚组可能有助于临床医生制定更个性化的治疗方案以改善母婴结局。

研究设计与样本

  • 这项队列研究分析了2015至2022年间两家中欧医院共2682例妊娠期糖尿病女性的数据集,其中柏林夏里特大学医院1865例、维也纳医科大学817例。
  • 研究评估了k-means、k-medoids和凝聚层次聚类等多种聚类模型,采用内部验证技术指导最佳模型选择,并在独立测试集上进行外部验证以评估模型泛化能力。

主要发现

  • 最优模型基于常规可用变量(母亲年龄、孕前BMI、诊断性OGTT空腹、60分钟和120分钟血糖)识别出三个聚类。
  • 第1组以最高OGTT值和最高肥胖患病率为特征;第2组孕前BMI居中且OGTT空腹血糖升高;第3组主要由孕前BMI正常且OGTT60和OGTT120血糖较高的参与者组成。
  • 第1组降糖药物需求为39.6%,第2组为12.9%,第3组为10.0%(p<0.0001)。
  • 第1组大于胎龄儿风险更高;外部验证队列中观察到第2组与第3组胰岛素治疗类型存在差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Gestational diabetes mellitus (GDM) is a heterogeneous condition. Given such variability among patients, the ability to recognise distinct GDM subgroups using routine clinical variables may guide more personalised treatments. Our main aim was to identify distinct GDM subtypes through cluster analysis using routine clinical variables, and analyse treatment needs and pregnancy outcomes across these subgroups. METHODS: In this cohort study, we analysed datasets from a total of 2682 women with GDM treated at two central European hospitals (1865 participants from Charité University Hospital in Berlin and 817 participants from the Medical University of Vienna), collected between 2015 and 2022. We evaluated various clustering models, including k-means, k-medoids and agglomerative hierarchical clustering. Internal validation techniques were used to guide best model selection, while external validation on independent test sets was used to assess model generalisability. Clinical outcomes such as specific treatment needs and maternal and fetal complications were analysed across the identified clusters. RESULTS: Our optimal model identified three clusters from routinely available variables, i.e. maternal age, pre-pregnancy BMI (BMIPG) and glucose levels at fasting and 60 and 120 min after the diagnostic OGTT (OGTT0, OGTT60 and OGTT120, respectively). Cluster 1 was characterised by the highest OGTT values and obesity prevalence. Cluster 2 displayed intermediate BMIPG and elevated OGTT0, while cluster 3 consisted mainly of participants with normal BMIPG and high values for OGTT60 and OGTT120. Treatment modalities and clinical outcomes varied among clusters. In particular, cluster 1 participants showed a much higher need for glucose-lowering medications (39.6% of participants, compared with 12.9% and 10.0% in clusters 2 and 3, respectively, p<0.0001). Cluster 1 participants were also at higher risk of delivering large-for-gestational-age infants. Differences in the type of insulin-based treatment between cluster 2 and cluster 3 were observed in the external validation cohort. CONCLUSIONS/INTERPRETATION: Our findings confirm the heterogeneity of GDM. The identification of subgroups (clusters) has the potential to help clinicians define more tailored treatment approaches for improved maternal and neonatal outcomes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Salvatori B, Wegener S, Kotzaeridi G, et al. Identification and validation of gestational diabetes subgroups by data-driven cluster analysis. Diabetologia. 2024. PMID: 38801521. doi:10.1007/s00125-024-06184-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。